Based in Research Triangle Park, North Carolina, Qmera Pharmaceuticals is an analytical CRO that leverages high‑resolution LC‑MS/MS, robust DMPK, bioanalysis, analytical chemistry, and pre‑formulation services to accelerate early‑stage drug development. Qmera’s PhD‑led teams deliver rapid project start‑up, scientific agility, and data excellence that equip sponsors to make timely, informed decisions.
Qmera’s agile team leverages decades of pharmaceutical industry experience to streamline the product development process and decrease the cost of drug discovery. Clear communication, fast assay turnaround, and secure access to data and protocols via an electronic laboratory notebook (ELN) create results you can trust.
LC- high-resolution mass spectrometry (LC-QTOF), UHPLC-PDA (1000 bars), UHPLC-CAD, UV photometry